Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation lmmunoenzymatic methods for the detection of antibodies to citrullinated proteins

被引:76
作者
Bizzaro, Nicola
Tonutti, Elio
Tozzoli, Renato
Villalta, Danilo
机构
[1] Osped Civile, Lab Patol Clin, I-33028 Tolmezzo, Italy
[2] Hosp Tolmezzo, Clin Pathol Lab, Tolmezzo, Italy
[3] Hosp Univ S Maria Misericordia, Udine, Italy
[4] Hosp Latisana, Lab Clin Chem & Microbiol, Latisana, Italy
[5] Hosp S Maria Angeli, Clin Immunol & Virol, Pordenone, Italy
关键词
D O I
10.1373/clinchem.2007.087569
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Measurement of antibodies to citrullinated peptides or proteins (CP) is a new test for the diagnosis of rheumatoid arthritis (RA). We analyzed the analytical characteristics and diagnostic accuracy of commercially available methods. Methods: We studied 11 commercially available 2nd and 3rd-generation methods that used various citrullinated antigen substrates: synthetic cyclic peptides, recombinant rat filaggrin, mutated human vimentin, and Epstein-Barr virus- or IgG-derived peptides. We assessed imprecision by measuring samples with low, intermediate, and high concentrations 5 times on each of 5 days. We measured CPs by each of the assays in 100 serum samples from patients with RA and in 202 samples from healthy persons or patients with other autoimmune, viral, or neoplastic diseases. Results: The between-run imprecision (CV) of the methods was between 0.4% and 22%, and the repeatability (within-run imprecision) was 0.5%-19%. The areas under the ROC curves varied between 0.79 (95% CI, 0.72-0.85) and 0.92 (0.88-0.95). At a fixed specificity of 98.5%, the sensitivities ranged from 41% (95% Cl, 31%51%) to 74% (64%-82%). Sensitivities and specificities varied markedly at the manufacturer's suggested cutoffs. Most false-positive results were recorded in patients with viral infections. The methods that use the original synthetic cyclic CP gave the best and very similar performances, although these methods use different components in their reagent sets (conjugate, type of substrate, dilution, and washing buffers). This finding shows that the antigenic source is the most important variable in determining the diagnostic accuracy of the methods. Conclusions: The analytical imprecision and diagnostic accuracies of commercially available methods for the detection of anti-CP antibodies differ. Careful selection of methods is needed. (c) 2007 American Association for Clinical Chemistry.
引用
收藏
页码:1527 / 1533
页数:7
相关论文
共 37 条
[31]   Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis [J].
Vallbracht, I ;
Rieber, J ;
Oppermann, M ;
Förger, F ;
Siebert, U ;
Helmke, K .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (09) :1079-1084
[32]   A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis [J].
van Gaalen, FA ;
Visser, H ;
Huizinga, TWJ .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1510-1512
[33]  
van Jaarsveld CHM, 1999, CLIN EXP RHEUMATOL, V17, P689
[34]   Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays [J].
Vander Cruyssen, Bert ;
Cantaert, Tineke ;
Nogueira, Leonor ;
Clavel, Cyril ;
De Rycke, Leen ;
Dendoven, Amelie ;
Sebag, Mireille ;
Deforce, Dieter ;
Vincent, Christian ;
Elewaut, Dirk ;
Serre, Guy ;
De Keyser, Filip .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (04)
[35]   How to diagnose rheumatoid arthritis early - A prediction model for persistent (erosive) arthritis [J].
Visser, H ;
le Cessie, S ;
Vos, K ;
Breedveld, FC ;
Hazes, JMW .
ARTHRITIS AND RHEUMATISM, 2002, 46 (02) :357-365
[36]  
Vossenaar E R, 2005, Ann Rheum Dis, V64, P1513, DOI 10.1136/ard.2005.045716
[37]   Absence of antibodies to cyclic citrullinated peptide in sera of patients and with hepatitis C virus infection cryoglobulinemia [J].
Wener, MH ;
Hutchinson, K ;
Morishima, C ;
Gretch, DR .
ARTHRITIS AND RHEUMATISM, 2004, 50 (07) :2305-2308